Track all markets on TradingView
A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics
Media

A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics

  • November 12, 2024
  • 2 Views

Latest Ratings for FOLD

Date Firm Action From To
Feb 2022 SVB Leerink Maintains Outperform
Jan 2022 SVB Leerink Upgrades Market Perform Outperform
Jan 2022 Cantor Fitzgerald Maintains Overweight

View More Analyst Ratings for FOLD

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for FOLD
DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Jan 2022SVB LeerinkUpgradesMarket PerformOutperform Jan 2022Cantor FitzgeraldMaintainsOverweight
View More Analyst Ratings for FOLD

View the Latest Analyst Ratings

read more 

Share This Post:

Leave a Reply

Your email address will not be published. Required fields are marked *

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.